Predictive biomarkers of preeclampsia severity in a low resource setting: Role of red blood cell indices, NLR, and albumin-to-creatinine ratio
- PMID: 39280265
- PMCID: PMC11391963
- DOI: 10.52225/narra.v4i2.729
Predictive biomarkers of preeclampsia severity in a low resource setting: Role of red blood cell indices, NLR, and albumin-to-creatinine ratio
Abstract
Preeclampsia (PE), a serious medical condition with substantial maternal and perinatal implications, poses a significant challenge, particularly in high-incidence countries like Indonesia. Red blood cell (RBC) indices, neutrophil-to-lymphocyte ratio (NLR), and microalbuminuria (albumin-to-creatinine ratio (ACR)) may signal systemic inflammation and endothelial dysfunction, recently recognized as potential indicators for diagnosing and predicting disease severity. The aim of this study was to analyze RBC indices, NLR, and ACR changes in women with PE and their potential for predicting disease severity. A cross-sectional study was conducted at multi-center hospitals across Medan, Indonesia, from June 2022 to June 2023. The patients were grouped into PE cases with and without severe features. Demographic characteristics and complications were recorded while blood and urine were tested. The Chi-squared test, Fisher's exact test and Mann-Whitney test were used to determine biomarkers associated with severe PE. A total of 208 PE patients were included in the study (104 patients for each PE with and without severe features). Our data indicated that PE patients with severe features had higher red cell distribution width (18.5% vs 13.7%; p<0.001), NLR (5.66% vs 4.1%; p<0.001), and ACR (755.97 mg/dL vs 468.63 mg/dL; p<0.001) compared to those without severe features. In contrast, the platelet count was lower in severe features than those without (21.9 × 106/μL vs 27.0 × 106/μL; p=0.002). This study highlighted that PE patients with severe features predominantly had higher levels of RDW, NLR, and ACR and lower platelet counts compared to those without severe features. Therefore, basic tests such as complete blood count and urinalysis, which are inexpensive and feasible in primary care settings with limited resources, offer hope as valuable diagnostic biomarkers for pregnant women diagnosed with PE in a low resource setting.
Keywords: Preeclampsia; albumin-to-creatinine ratio; diagnostic marker; neutrophil-to-lymphocyte ratio; red blood cell index.
© 2024 The Author(s).
Conflict of interest statement
All authors affirm that they have no conflicts of interest.
Similar articles
-
Role of neutrophil / lymphocyte ratio, uric acid / albumin ratio and uric acid / creatinine ratio as predictors to severity of preeclampsia.BMC Pregnancy Childbirth. 2023 Oct 30;23(1):763. doi: 10.1186/s12884-023-06083-6. BMC Pregnancy Childbirth. 2023. PMID: 37904105 Free PMC article.
-
Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, red cell distribution width and plateletcrit in preeclampsia.Pregnancy Hypertens. 2017 Jan;7:29-32. doi: 10.1016/j.preghy.2016.12.002. Epub 2016 Dec 23. Pregnancy Hypertens. 2017. PMID: 28279444
-
Assessment efficacy of neutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in preeclampsia.J Reprod Immunol. 2019 Apr;132:29-34. doi: 10.1016/j.jri.2019.02.001. Epub 2019 Mar 6. J Reprod Immunol. 2019. PMID: 30861482
-
Investigating the association of albuminuria with the incidence of preeclampsia and its predictive capabilities: a systematic review and meta-analysis.BMC Pregnancy Childbirth. 2025 Mar 20;25(1):322. doi: 10.1186/s12884-025-07444-z. BMC Pregnancy Childbirth. 2025. PMID: 40114106 Free PMC article.
-
Predictive role of neutrophil-to-lymphocyte ratio in preeclampsia: A meta-analysis including 3982 patients.Pregnancy Hypertens. 2020 Apr;20:111-118. doi: 10.1016/j.preghy.2020.03.009. Epub 2020 Mar 24. Pregnancy Hypertens. 2020. PMID: 32279029
Cited by
-
First-trimester neutrophil percentage-to-albumin ratio: a novel predictor for preeclampsia.Biomark Med. 2025 Jun;19(11):415-423. doi: 10.1080/17520363.2025.2511468. Epub 2025 May 25. Biomark Med. 2025. PMID: 40415382
References
-
- Wong TY, Groen H, Faas MM, et al. . Clinical risk factors for gestational hypertensive disorders in pregnant women at high risk for developing preeclampsia. Pregnancy Hypertens 2013;3(4):248–253. - PubMed
-
- Say L, Chou D, Gemmill A, et al. . Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health 2014;2(6):323–333. - PubMed
-
- Safirani NAN, Fulyani F, Wiyati PS, et al. . The difference of platelet-white blood cell ratio in severe preeclampsia and normotensive pregnancy. Bali Med J 2022;11(1):414–417.
-
- Liwang F, Bhargah A.. Preeclampsia management: Different insight from hospital to hospital approach in Indonesia. Indones J Biomed Sci 2019;13(1):1–6.
-
- Singgih R, Firmansyah Y, Dewi AK. Clinical ability of neutrophil-lymphocyte ratio in pregnancy as a predictor of preeclampsia. J South Asian Fed Obstet Gynaecol 2021;13(3):121–126.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources